Can you believe this? Ticagrelor approved for Primary Prevention of STEMI
It’s all happening. FDA approves Ticagrelor for high-risk cad primary prevention and stroke. I am sure, even Astra Zenica wouldn’t have expected this. At best, the evidence from THEMIS for this Indication, can be called as a statistical extrapolation of comical proportion.
Meanwhile, Ticagrelor thanks Aspirin for its extreme kindness for agreeing to co-live with it.
The twitter reacts. This one is fromDr. Davide Capodanno , current Editor In chief , of EuroIntervention, the journal with one of the top Impact factor with a huge following.